Prospect Financial Services LLC Actinium Pharmaceuticals, Inc. Transaction History
Prospect Financial Services LLC
- $180 Billion
- Q1 2025
A detailed history of Prospect Financial Services LLC transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Prospect Financial Services LLC holds 12,000 shares of ATNM stock, worth $18,960. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,000
Previous 12,400
3.23%
Holding current value
$18,960
Previous $15.6 Million
23.66%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ATNM
# of Institutions
72Shares Held
8.18MCall Options Held
51.9KPut Options Held
6.2K-
Black Rock Inc. New York, NY1.88MShares$2.96 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.57MShares$2.48 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA712KShares$1.12 Million0.0% of portfolio
-
State Street Corp Boston, MA645KShares$1.02 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA504KShares$796,3800.0% of portfolio
About Actinium Pharmaceuticals, Inc.
- Ticker ATNM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,184,700
- Market Cap $39.8M
- Description
- Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...